Your browser doesn't support javascript.
loading
Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation.
Melixetian, Marine; Bossi, Daniela; Mihailovich, Marija; Punzi, Simona; Barozzi, Iros; Marocchi, Federica; Cuomo, Alessandro; Bonaldi, Tiziana; Testa, Giuseppe; Marine, Jean-Christophe; Leucci, Eleonora; Minucci, Saverio; Pelicci, Pier Giuseppe; Lanfrancone, Luisa.
Afiliación
  • Melixetian M; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Bossi D; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Mihailovich M; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Punzi S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Barozzi I; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Marocchi F; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Cuomo A; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Bonaldi T; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Testa G; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Marine JC; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
  • Leucci E; Laboratory for Molecular Cancer Biology, Department of Oncology, KULeuven, Leuven, Belgium.
  • Minucci S; Center for Cancer Biology, VIB, Leuven, Belgium.
  • Pelicci PG; Laboratory for RNA Cancer Biology, Department of Oncology, KULeuven, Leuven, Belgium.
  • Lanfrancone L; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
EMBO Rep ; 22(3): e50852, 2021 03 03.
Article en En | MEDLINE | ID: mdl-33586907
ABSTRACT
Transition from proliferative-to-invasive phenotypes promotes metastasis and therapy resistance in melanoma. Reversion of the invasive phenotype, however, is challenged by the poor understanding of mechanisms underlying its maintenance. Here, we report that the lncRNA TINCR is down-regulated in metastatic melanoma and its silencing increases the expression levels of invasive markers, in vitro migration, in vivo tumor growth, and resistance to BRAF and MEK inhibitors. The critical mediator is ATF4, a central player of the integrated stress response (ISR), which is activated in TINCR-depleted cells in the absence of starvation and eIF2α phosphorylation. TINCR depletion increases global protein synthesis and induces translational reprogramming, leading to increased translation of mRNAs encoding ATF4 and other ISR proteins. Strikingly, re-expression of TINCR in metastatic melanoma suppresses the invasive phenotype, reduces numbers of tumor-initiating cells and metastasis formation, and increases drug sensitivity. Mechanistically, TINCR interacts with mRNAs associated with the invasive phenotype, including ATF4, preventing their binding to ribosomes. Thus, TINCR is a suppressor of the melanoma invasive phenotype, which functions in nutrient-rich conditions by repressing translation of selected ISR RNAs.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / ARN Largo no Codificante / Melanoma Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / ARN Largo no Codificante / Melanoma Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article